参考文献/References:
[1] 汪敏加,齐梓伊,朱玮华,等.肌肉萎缩机制及临床研究进展:基于第65届美国运动医学学会年会的思考[J].中国组织工程研究,2019,23(15):2421-2426.DOI:10.3969/j.issn.2095-4344.1134.
[2] 马淑梅,陈瑶,刘莉.肌肉萎缩症治疗的研究进展[J].世界临床药物,2017,38(11):790-792,73-74.DOI:10.13683/j.wph.2017.11.014.
[3] Zizzo J.Muscle Atrophy Classification:The Need for a Pathway-Driven Approach[J].Curr Pharm Des,2021.DOI:10.2174/1381612824666210316102413.
[4] Tieland M,Trouwborst I,Clark BC.Skeletal muscle performance and ageing[J].J Cachexia Sarcopenia Muscle,2018,9(1):3-19.DOI:10.1002/jcsm.12238.
[5] 张建,顾茵,罗学胜,等.华东地区老年骨骼肌萎缩的流行性和相关因素[J].中国老年学杂志,2018,38(19):4806-4808.DOI:10.3969/j.issn.1005-9202.2018.19.072.
[6] Howard EE,Pasiakos SM,Fussell MA,et al.Skeletal Muscle Disuse Atrophy and the Rehabilitative Role of Protein in Recovery from Musculoskeletal Injury[J].Adv Nutr,2020,11(4):989-1001.DOI:10.1093/advances/nmaa015.
[7] Vitadello M,Sorge M,Percivalle E,et al.Loss of melusin is a novel,neuronal NO synthase/FoxO3-independent master switch of unloading-induced muscle[J].J Cachexia Sarcopenia Muscle,2020,11(3):802-819.DOI:10.1002/jcsm.12546.
[8] 潘建延,谭虎,周妙金,等.脊髓性肌萎缩症的临床实践指南[J].中华医学遗传学杂志,2020,37(3):263-268.DOI:10.3760/cma.j.issn.1003-9406.2020.03.007.
[9] 张雨丹,刘仕群,范存霞,等.胰高血糖素样肽1受体激动剂对2型糖尿病合并超重/肥胖患者不同部位脂肪分布及肌肉含量的影响[J].南方医科大学学报,2019,39(4):450-455.DOI:10.12122/j.issn.1673-4254.2019.04.11.
[10] Hong Y,Lee JH,Jeong KW,et al.Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy[J].J Cachexia Sarcopenia Muscle,2019,10(4):903-918.DOI:10.1002/jcsm.12434.
[11] 郑莉芳,陈佩杰,肖卫华.骨骼肌质量控制信号通路[J].生理学报,2019,71(4):671-679.DOI:10.13294/j.aps.2019.0021.
[12] 王继,周越,张荷,等.Myostatin信号通路在4周离心耐力运动改善2型糖尿病大鼠骨骼肌萎缩中的作用[J].中国应用生理学杂志,2018,34(3):223-228,282.DOI:10.12047/j.cjap.5632.2018.053.
[13] Choi DH,Yang J,Kim YS.Rapamycin suppresses postnatal muscle hypertrophy induced by myostatin-inhibition accompanied by transcriptional suppression of the Akt/mTOR pathway[J].Biochem Biophys Rep,2019,17:182-190.DOI:10.1016/j.bbrep.2018.12.009.
[14] Samant SA,Kanwal A,Pillai VB,et al.The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy[J].Sci Rep,2017,7(1):11877.DOI:10.1038/s41598-017-10838-5.
[15] Petry ÉR,Dresch DF,Carvalho C,et al.Oral glutamine supplementation attenuates inflammation and oxidative stress-mediated skeletal muscle protein content degradation in immobilized rats:Role of 70 kDa heat shock protein[J].Free Radic Biol Med,2019,145:87-102.DOI:10.1016/j.freeradbiomed.2019.08.033.
[16] 宋冠军.荷叶碱等几种植物降糖功能成分对GLUT4的作用机制[D].武汉:中南民族大学,2018.
[17] Xiong R,Wang XL,Wu JM,et al.Polyphenols isolated from lychee seed inhibit Alzheimer's disease-associated Tau through improving insulin resistance via the IRS-1/PI3K/Akt/GSK-3β pathway[J].J Ethnopharmacol,2020,251:112548.DOI:10.1016/j.jep.2020.112548.
[18] 姚瑶.rhGLP-1(7-36)联合他克莫司对肝细胞Akt/mTOR/p70S6K及Akt/GSK3信号通路的影响[D].锦州:锦州医科大学,2019.
[19] Zhou M,Chen S,Peng P,et al.Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β[J].Biochem Biophys Res Commun,2019,511(1):154-160.DOI:10.1016/j.bbrc.2019.01.103.
[20] Andreozzi F,Raciti GA,Nigro C,et al.The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism[J].J Transl Med,2016,14(1):229.DOI:10.1186/s12967-016-0985-7.
[21] 李瑾,白瑞,秦卫伟,等.晚期糖基化终产物对心肌细胞葡萄糖转运蛋白4表达的影响及p38丝裂原活化蛋白激酶作用的研究[J].中国药物与临床,2018,18(8):1289-1292.DOI:10.11655/zgywylc2018.08.007.
[22] Cai HY,Yang JT,Wang ZJ,et al.Lixisenatide reduces amyloid plaques,neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimer's disease.Biochem Biophys Res Commun[J].2018,495(1):1034-1040.DOI:10.1016/j.bbrc.2017.11.114.
[23] Yoo M,Lee SJ,Kim YK,et al.Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation[J].Mol Med Rep,2016,14(4):3029-3036.DOI:10.3892/mmr.2016.5653.
[24] 杨栋,莫中成.姜黄素对过度训练大鼠骨骼肌p38 MAPK的表达及抗氧化能力的影响[J].中国体育科技,2019,55(2):76-80.DOI:10.16470/j.csst.2019893.
[25] 刘剑.利拉鲁肽对高脂喂养大鼠胰岛素抵抗和骨骼肌脂质沉积的影响及相关机制的探讨[D].承德医学院,2016.
[26] Cao HY,Xu F,Chen ZL,et al.Effect of exendin-4 on lipid deposition in skeletal muscle of diet-induced obese mice and its underlying mechanism[J].Zhonghua Yi Xue Za Zhi,2017,97(2):131-136.DOI:10.3760/cma.j.issn.0376-2491.2017.02.011.
[27] Madonna R,Confalone P,Doria V,et al.Effects of simulated hyperglycemia in vitro on insulin signaling in endothelial cells[J].Vascul Pharmacol,2018,103-105:52-53.DOI:10.1016/j.vph.2017.12.016.
[28] Tan AWK,Subaran SC,Sauder MA,et al.GLP-1 and Insulin Recruit Muscle Microvasculature and Dilate Conduit Artery Individually But Not Additively in Healthy Humans[J].J Endocr Soc,2018,2(2):190-206.DOI:10.1210/js.2017-00446.
[29] Smits MM,Muskiet MH,Tonneijck L,et al.GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight Men[J].Arterioscler Thromb Vasc Biol,2015,35(6):1538-1543.DOI:10.1161/ATVBAHA.115.305447.
[30] Gurjar AA,Kushwaha S,Chattopadhyay S,et al.Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents[J].Metabolism,2020,103:154044.DOI:10.1016/j.metabol.2019.154044.
[31] 马美琳.miRNa-432在成肌细胞增殖分化中的作用及机制研究[D].咸阳:西北农林科技大学,2017.
[32] 万小凤,唐成林,赵丹丹,等.推拿对失神经骨骼肌萎缩大鼠的治疗作用及其机制[J].中国应用生理学杂志,2019,35(3):223-227,267.DOI:10.12047/j.cjap.5726.2019.048.
[33] 刘玉琴,刘元涛.胰高血糖素样肽-1及其相关药物与神经保护[J].青岛大学学报(医学版),2018,54(4):483-486.DOI:10.11712/jms201804027.
相似文献/References:
[1]田甜,沈山梅.肠促胰素与骨质疏松[J].国际内分泌代谢杂志,2016,36(05):320.[doi:10.3760/cma.j.issn.1673-4157.2016.05.09]
Tian Tian,Shen Shanmei.Incretin and osteoporosis[J].International Journal of Endocrinology and Metabolism,2016,36(01):320.[doi:10.3760/cma.j.issn.1673-4157.2016.05.09]
[2]刘海逸,张欣荣,岳晓丹,等.黄连解毒汤对糖耐量减低大鼠的糖尿病
延缓作用[J].国际内分泌代谢杂志,2017,37(03):149.[doi:10.3760/cma.j.issn.1673-4157.2017.03.002]
Liu Haiyi*,Zhang Xinrong,Yue Xiaodan,et al.Effects of huang-lian-jie-du-decoction in delaying diabetes in rats with impaired glucose tolerance[J].International Journal of Endocrinology and Metabolism,2017,37(01):149.[doi:10.3760/cma.j.issn.1673-4157.2017.03.002]
[3]叶勇健 潘天荣.GLP-1受体激动剂在肥胖相关性肾病中的作用机制[J].国际内分泌代谢杂志,2019,39(01):45.[doi:10.3760/cma.j.issn.1673-4157.2019.01.011]
Ye Yongjian,Pan Tianrong.Mechanisms of GLP-1 receptor agonist in obesity-related glomerulopathy[J].International Journal of Endocrinology and Metabolism,2019,39(01):45.[doi:10.3760/cma.j.issn.1673-4157.2019.01.011]
[4]杨梦萦 袁莉.胰岛内源性胰高血糖素样肽-1信号的研究进展[J].国际内分泌代谢杂志,2019,39(06):413.[doi:10.3760/cma.j.issn.1673-4157.2019.06.013]
Yang Mengying,Yuan Li.Recent progress of the islet endogenous glucagon-like peptide-1 signaling[J].International Journal of Endocrinology and Metabolism,2019,39(01):413.[doi:10.3760/cma.j.issn.1673-4157.2019.06.013]